Psychedelics Today

PT 617 - Alan Davis - Psychedelic Research and Patient Safety at Ohio State & Exploring Ibogaine's Potential


Listen Later

In this episode of Psychedelics Today, Joe Moore sits down with Alan Davis, Associate Professor at Ohio State University, to explore the evolving landscape of Ibogaine research and its therapeutic potential.

Alan offers a deep dive into the Iboga Patient Survey, a groundbreaking initiative collecting real-world data on the safety and efficacy of Ibogaine—particularly for those struggling with substance use disorders and mental health challenges. The conversation sheds light on the need for rigorous, community-informed research that could pave the way toward FDA approval and increased access for patients, including veterans dealing with trauma.

They also discuss the complexities of clinical trials, the tension between state and federal regulations, and the growing influence of corporate interests in psychedelic research. Alan emphasizes the importance of ethical transparency, community collaboration, and maintaining scientific integrity as the field grows.

If you're curious about the intersection of psychedelic medicine, clinical research, and patient safety, this is a must-listen episode.

Topics Covered
  • 00:00 – Introduction and Guest Welcome

  • 00:53 – Reflecting on COVID-19's Psychological Impact

  • 01:29 – Introducing the Iboga Patient Survey

  • 01:46 – History and Goals of Ibogaine Research

  • 02:41 – Challenges in Conducting Clinical Trials

  • 03:14 – Importance of Real-World Safety Data

  • 06:55 – Personal Interest in Ibogaine

  • 08:56 – Veterans and Trauma: A Personal Connection

  • 10:53 – Reintegration and Emotional Processing

  • 15:29 – Survey Participation and Accessibility

  • 18:25 – Building Partnerships and Overcoming Challenges

  • 21:06 – Ensuring Safety and Transparency

  • 31:49 – Community and Academic Collaboration

  • 33:06 – Survey Design and Future Research Directions

  • 36:50 – Momentum in Psychedelic Research

  • 37:48 – State vs. Federal Regulation

  • 39:23 – Challenges in Psychedelic Treatment

  • 43:01 – Corporate Interests and Scientific Objectivity

  • 47:20 – Ketamine and Collaborative Research

  • 51:56 – Ibogaine Patient Survey

  • 57:55 – Psychedelics and Pain Research

  • 01:07:22 – Conclusion and Future Directions

...more
View all episodesView all episodes
Download on the App Store

Psychedelics TodayBy Psychedelics Today

  • 4.6
  • 4.6
  • 4.6
  • 4.6
  • 4.6

4.6

547 ratings


More shows like Psychedelics Today

View all
Tara Brach by Tara Brach

Tara Brach

10,449 Listeners

Sounds True: Insights at the Edge by Tami Simon

Sounds True: Insights at the Edge

1,843 Listeners

Ram Dass Here And Now by Ram Dass / Love Serve Remember

Ram Dass Here And Now

2,574 Listeners

Tricycle Talks by Tricycle: The Buddhist Review

Tricycle Talks

351 Listeners

The Wisdom Podcast by The Wisdom Podcast

The Wisdom Podcast

326 Listeners

10% Happier with Dan Harris by 10% Happier

10% Happier with Dan Harris

12,581 Listeners

THIRD EYE DROPS by Michael Phillip

THIRD EYE DROPS

1,242 Listeners

The Psychedelic Podcast by Third Wave

The Psychedelic Podcast

298 Listeners

This Jungian Life Podcast by Joseph Lee, Deborah Stewart, Lisa Marchiano

This Jungian Life Podcast

1,555 Listeners

The Emerald by Joshua Schrei

The Emerald

956 Listeners

Back from the Abyss: Psychiatry in Stories by Craig Heacock MD

Back from the Abyss: Psychiatry in Stories

463 Listeners

Plants of the Gods: Hallucinogens, Healing, Culture and Conservation podcast by Mark Plotkin, Ph.D.

Plants of the Gods: Hallucinogens, Healing, Culture and Conservation podcast

258 Listeners

Psychedelic Therapy Frontiers by Numinus Network

Psychedelic Therapy Frontiers

172 Listeners

Sounds of SAND by Science and Nonduality

Sounds of SAND

106 Listeners

Tetragrammaton with Rick Rubin by Rick Rubin

Tetragrammaton with Rick Rubin

1,014 Listeners